Indegene moves up on partnering with Indian School of Public Policy
Indegene is currently trading at Rs. 547.50, up by 4.05 points or 0.75% from its previous closing of Rs. 543.45 on the BSE.
The scrip opened at Rs. 540.35 and has touched a high and low of Rs. 547.95 and Rs. 539.45 respectively. So far 1067 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 736.60 on 01-Oct-2024 and a 52 week low of Rs. 468.90 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 562.40 and Rs. 529.20 respectively. The current market cap of the company is Rs. 13140.44 crore.
The Institutions and Non-Institutions held 10.20% and 89.80% stake in the company respectively.
Indegene has partnered with Indian School of Public Policy (ISPP), a premier public policy school built by veteran policy leaders, to advance health policy research and design in the country. As part of this collaboration, ISPP will analyze health systems across states, identifying scalable models and actionable insights to strengthen India's healthcare delivery. This will help co-create evidence-based, context-specific solutions to inform and shape impactful public policy.
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.
